Intrinsiqs

Is Protagonist Therapeutics, Inc. overvalued?

Protagonist Therapeutics, Inc. (PTGX) — key valuation metrics and fundamentals.

No verdict
Price
$151.42
Fair value
Current P/E
Normal P/E
Market cap
$9.74B
Dividend yield
0.0%
Return on equity
12.0%
Sector
Healthcare

See the full interactive analysis →

Fair value compares PTGX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.